Related Experiment Video
Updated: May 5, 2026
Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
Targeting Fks1 proteins for novel antifungal drug discovery
Vinit Kumar1, Juan Huang2, Yawen Dong2
1National Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for Research and Development of Fine Chemicals, Guizhou University, Guiyang 550025, PR China; BMLT, Markham College of Commerce, Vinoba Bhave University, Hazaribagh, Jharkhand 825301, India.
Abstract:
Fungal infections are a major threat to human health. The limited availability of antifungal drugs, the emergence of drug resistance, and a growing susceptible population highlight the critical need for novel antifungal agents. The enzymes involved in fungal cell wall synthesis offer potential targets for antifungal drug development. Recent studies have enhanced our focus on the enzyme Fks1, which synthesizes β-1,3-glucan, a critical component of the cell wall. These studies provide a deeper understanding of Fks1's function in cell wall biosynthesis, pathogenicity, structural biology, evolutionary conservation across fungi, and interaction with current antifungal drugs. Here, we discuss the role of Fks1 in the survival and adaptation of fungi, guided by insights from evolutionary and structural analyses. Furthermore, we delve into the dynamics of Fks1 modulation with novel antifungal strategies and assess its potential as an antifungal drug target.
Insights
Novel antifungal strategies targeting the Fks1 enzyme, crucial for fungal cell wall synthesis, are needed due to drug resistance. Understanding Fks1
Area of Science:
- Mycology
- Biochemistry
- Drug Discovery
Background:
- Fungal infections pose a significant global health threat.
- Limited antifungal drug options and rising drug resistance necessitate new therapeutic approaches.
- Enzymes in fungal cell wall synthesis are promising targets for novel antifungal agents.
Purpose of the Study:
- To explore the enzyme Fks1, a key component in fungal cell wall biosynthesis.
- To review the role of Fks1 in fungal survival, adaptation, and pathogenicity.
- To assess Fks1 as a potential target for developing new antifungal drugs.
Main Methods:
- Literature review focusing on Fks1 function, structure, and evolution.
- Analysis of Fks1's role in fungal cell wall biosynthesis.
- Evaluation of Fks1 modulation strategies for antifungal development.
Main Results:
- Fks1 synthesizes beta-1,3-glucan, essential for fungal cell wall integrity.
- Evolutionary and structural insights reveal Fks1's conserved importance across fungi.
- Fks1 interactions with existing antifungal drugs are documented.
Conclusions:
- Fks1 is a critical target for novel antifungal drug development.
- Further research into Fks1 modulation can lead to effective antifungal strategies.
- Targeting Fks1 offers a promising avenue to combat fungal infections and resistance.
More Related Videos
05:57Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
Published on: April 26, 2024
08:29Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Published on: October 4, 2024
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
01:15Antifungal Agents